Gut microbiota and obesity. Can probiotics help?

Cover Page

Cite item


The high prevalence of obesity in children and adolescents, the complexity of therapy, a large number of comorbid conditions dictate the need for ongoing research into the causes of obesity and methods for its prevention. One of the newest and most promising aspects to study influencing the formation of obesity is the gut microbiota. The proposed mechanisms linking the gut microbiota to obesity are realized through strain-specific effects of bacteria on changes in the host's metabolism. Probiotics affect the microbiota directly by modulating its composition and indirectly through bacteriocins produced by probiotic bacteria. There is great scientific interest in the use of probiotics as part of therapy or for the prevention of obesity.

Full Text

Restricted Access

About the authors

Irina N. Zakharova

Russian Medical Academy of Continuous Professional Education

Author for correspondence.
ORCID iD: 0000-0003-4200-4598

D. Sci. (Med.), Prof.

Russian Federation, Moscow

Irina V. Berezhnaya

Russian Medical Academy of Continuous Professional Education

ORCID iD: 0000-0001-5684-7575

Cand. Sci. (Med.)

Russian Federation, Moscow

Mariia A. Simakova

Russian Medical Academy of Continuous Professional Education

ORCID iD: 0000-0002-7994-3751

Graduate Student

Russian Federation, Moscow


  1. Bäckhed F, Roswall J, Peng Y, et al. Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. Cell Host Microbe. 2015;17(5):690-703.
  2. Muscogiuri G, Cantone E, Cassarano S, et al.; on behalf of the Obesity Programs of nutrition, Education, Research and Assessment (OPERA) group. Gut microbiota: a new path to treat obesity. Int J Obes Suppl. 2019;9(1):10-9.
  3. Moossavi S, Azad MB. Quantifying and Interpreting the Association between Early-Life Gut Microbiota Composition and Childhood Obesity. mBio. 2019;10(1):e02787-18.
  4. Stanislawski MA, Dabelea D, Wagner BD, et al. Gut Microbiota in the First 2 Years of Life and the Association with Body Mass Index at Age 12 in a Norwegian Birth Cohort. mBio. 2018;9(5):e01751-18.
  5. Haddad EN, Sugino KY, Kerver JM, et al. The infant gut microbiota at 12 months of age is associated with human milk exposure but not with maternal pre-pregnancy body mass index or infant BMI-for-age z-scores. Curr Res Physiol. 2021;4:94-102.
  6. Tun HM, Bridgman SL, Chari R, et al.; Canadian Healthy Infant Longitudinal Development (CHILD) Study Investigators. Roles of Birth Mode and Infant Gut Microbiota in Intergenerational Transmission of Overweight and Obesity From Mother to Offspring. JAMA Pediatr. 2018;172(4):368-77.
  7. Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Sci USA. 2004;101(44):15718-23. DOI:10.1073pnas.0407076101
  8. Dahiya DK, Renuka, Puniya M, et al. Gut Microbiota Modulation and Its Relationship with Obesity Using Prebiotic Fibers and Probiotics: A Review. Front Microbiol. 2017;8:563. doi: 10.3389/fmicb.2017.00563
  9. Kasubuchi M, Hasegawa S, Hiramatsu T, et al. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients. 2015;7(4):2839-49. doi: 10.3390/nu7042839
  10. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes Metab Res. 2007;56:1761-72. doi: 10.2337/db06-1491
  11. Louis S, Tappu RM, Damms-Machado A, et al. Characterization of the gut microbial Community of Obese Patients Following a weight-loss intervention using whole Metagenome shotgun sequencing. PLoS One. 2016;11(2):e0149564. doi: 10.1371/journal.pone.0149564
  12. De Silva A, Bloom SR. Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity. Gut Liver. 2012;6:10-20. doi: 10.5009/gnl.2012.6.1.10
  13. Aron-Wisnewsky J, Gaborit B, Dutour A, Clement K. Gut microbiota and non-alcoholic fatty liver disease: new insights. Clin Microbiol Infect. 2013;19(4):338-48. doi: 10.1111/1469 0691.12140
  14. Million M, Maraninchi M, Henry M, et al. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes. 2012;36(6):817-25.
  15. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174-80. doi: 10.1038/nature09944
  16. Schwiertz A, Taras D, Schäfer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010;18(1):190-5. doi: 10.1038/oby.2009.167
  17. Choi SB, Lew LC, Yeo SK, et al. Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and Hyde scenario. Crit Rev Biotechnol. 2015;35(3):392-401. doi: 10.3109/07388551.2014.889077
  18. Jones ML, Martoni CJ, Parent M, Prakash S. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br J Nutr. 2012;107:1505-13.
  19. Shimizu M, Hashiguchi M, Shiga T, et al. Meta-Analysis: Effects of Probiotic Supplementation on Lipid Profiles in Normal to Mildly Hypercholesterolemic Individuals. PLOS One. 2015;16:116. doi: 10.1371/journal.pone.0139795
  20. Shavakhi A, Minakari M, Firouzian H, et al. Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial. Int J Prevent Med. 2013;4(5):531-7.
  21. Eslamparast T, Poustchi H, Zamani F, et al. Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Am J Clin Nutr. 2014;99:535-42.
  22. Ардатская М.Д. Клиническое применение пищевых волокон: метод. пособие. М.: 4ТЕ Арт, 2010 [Ardatskaia MD. Klinicheskoe primenenie pishchevykh volokon: metod. posobie. Moscow: 4TE Art, 2010 (in Russian)].
  23. Pal S, Ho S, Gahler RJ, Wood S. Effect on body weight and composition in overweight/obese Australian adults over 12 months consumption of two different types of fibre supplementation in a randomized trial. Nutr Metab. 2016;13:82-92. doi: 10.1186/s12986-016-0141–7
  24. De Bock M, Derraik JGB, Brennan CM, et al. Psyllium supplementation in adolescents improves fat distribution & lipid profile: a randomized, participant-blinded, placebo-controlled, crossover trial. PLoS One. 2012;7(7):41735. doi: 10.1371/journal.pone.0041735
  25. Abutair AS, Naser IA, Hamed AT. Soluble fibers from psyllium improve glycemic response and body weight among diabetes type 2 patients (randomized control trial). Nutr J. 2016;15:86-93. doi: 10.1186/s12937-016-0207-4
  26. Копчак Д.В. Клиническое обоснование эффективности использования пре- и пробиотиков у пациентов с метаболическим синдромом и нарушенным микробиоцинозом тонкой и толстой кишки. Автореф. дис. … канд. мед. наук. СПб., 2019 [Kopchak DV. Klinicheskoe obosnovanie effektivnosti ispol'zovaniia pre- i probiotikov u patsientov s metabolicheskim sindromom i narushennym mikrobiotsinozom tonkoi i tolstoi kishki. Avtoref. dis. … kand. med. nauk. Saint Petersburg, 2019 (in Russian)].
  27. Juul F, Hemmingsson E. Trends in consumption of ultra-processed foods and obesity in Sweden between 1960 and 2010. Public Health Nutr. 2015;18(17):3096-7.
  28. Neri D, Steele EM, Khandpur N, et al. Ultraprocessed food consumption and dietary nutrient profiles associated with obesity: A multicountry study of children and adolescents. Obes Rev. 2021;e13387.

Copyright (c) 2021 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74329 от 19.11.2018 г.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies